SEC 13F Intelligence

Managers / Q2 2019 · view latest →

Worth Venture Partners, LLC

CIK 0001696778 · 2 EXECUTIVE DRIVE, SUITE 515, FORT LEE, NJ, 07024 · 2125589017

Reported Value
$181M
Q2 2019
Positions
197
Filings on Record
30
2019–present window
Filed
Aug 14, 2019
original filing

Summary

Worth Venture Partners, LLC reported $181M in U.S.-listed holdings across 197 positions for Q2 2019.

Its largest position, Squre 0 375 03 01 22 Cvt Convertible 0 375 01 Mar 22, represents 17.9% of the portfolio.

Compared with Q1 2019, the fund opened 34 new positions and exited 33.

Portfolio Metrics

Turnover
+38.0%
vs prior filed quarter
Top-10 Concentration
+71.7%
share of reported value
Largest Position
+17.9%
Squre 0 375 03 01 22 Cvt Convertible 0 375 01 Mar 22
New / Exited
34 / 33
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $132MQ4 ’18Q1 ’19: $180MQ2 ’19: $181MQ3 ’19: $175MQ4 ’19: $204MQ4 ’19Q1 ’20: $162MQ2 ’20: $204MQ3 ’20: $122MQ4 ’20: $126MQ4 ’20Q1 ’21: $206MQ2 ’21: $269MQ3 ’21: $222MQ4 ’21: $202MQ4 ’21Q1 ’22: $217MQ2 ’22: $170MQ3 ’22: $163MQ4 ’22: $169MQ4 ’22Q1 ’23: $205MQ2 ’23: $184MQ3 ’23: $169MQ4 ’23: $185MQ4 ’23Q1 ’24: $15MQ2 ’24: $13MQ3 ’24: $14MQ4 ’24: $10MQ4 ’24Q1 ’25: $53MQ2 ’25: $65MQ3 ’25: $34MQ4 ’25: $14MQ4 ’25Q1 ’26: $32Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 67.4%Common Stock: 15.0%GLOBAL: 7.5%Other: 4.7%ETP: 4.2%Other: 1.2%
  • US DOMESTIC · 67.4% · $122M
  • Common Stock · 15.0% · $27M
  • GLOBAL · 7.5% · $14M
  • Other · 4.7% · $8M
  • ETP · 4.2% · $8M
  • Other · 1.2% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019

83 positions
#IssuerClass% PortfolioValueShares
1SQURE 0.375 03/01/22 CVT CONVERTIBLE 0.375 01 Mar 22NOTE 0.375% 3/2 · NOTE 0.375% 3/1 · NOTE 0.375% 3/017.86%$32M10.16M
2AMD 2.125 09/01/26 CVT CONVERTIBLE 2.125 01 Sep 26NOTE 2.125% 9/013.69%$25M6.38M
3CZR 5.000 10/01/24 CVT CONVERTIBLE 5.000 01 Oct 24NOTE 5.000%10/07.50%$14M7.83M
4SRPTX 1.500 11/15/24 CVT CONVERTIBLE 1.500 15 Nov 24DBCV 1.500%11/2 · DBCV 1.500%11/3 · DBCV 1.500%11/17.31%$13M5.93M
5ANTMX 2.750 10/15/42 CVT CONVERTIBLE 2.750 15 Oct 42NOTE 2.750%10/15.59%$10M2.58M
6WDAY 1.500 07/15/20 CVT CONVERTIBLE 1.500 15 Jul 20NOTE 1.500% 7/3 · NOTE 1.500% 7/1 · NOTE 1.500% 7/25.05%$9M3.61M
7RTRX 2.500 09/15/25 CVT CONVERTIBLE 2.500 15 Sep 25NOTE 2.500% 9/3 · NOTE 2.500% 9/1 · NOTE 2.500% 9/24.53%$8M9.06M
8NICE 1.250 01/15/24 CVT CONVERTIBLE 1.250 15 Jan 24NOTE 1.250% 1/14.30%$8M4.56M
9MDCO 2.750 07/15/23 CVT CONVERTIBLE 2.750 15 Jul 23NOTE 2.750% 7/13.13%$6M5.65M
10WMGI 2.250 11/15/21 CVT CONVERTIBLE 2.250 15 Nov 21NOTE 2.250%11/12.72%$5M3.31M
11TSLA 2.000 05/15/24 CVT CONVERTIBLE 2.000 15 May 24NOTE 2.000% 5/11.63%$3M3.00M
12COHREURCOHERENT ORDhistory →COM1.40%$3M18.5K
13AVID TECHNOLOGY INCNOTE 2.000% 6/11.30%$2M257.7K
14BMRNBIOMARIN PHARMACEUTICAL INChistory →COM1.30%$2M27.3K
15AVANTOR MANDTY CON SRS A PRF CONVERTIBLE PREFERRED 0.0006.25 PFD CNV SR1.10%$2M30.0K
16DZSIEURDASAN ZHONE SOLUTION ORDhistory →COM1.09%$2M151.1K
17ISHARES RUSSELL 2000 ETFRUSSELL 2000 ETF0.98%$2M11.4K
18BKNGBOOKING HOLDINGS ORDCOM0.95%$2M913
19Liberty Media 1.375 10/15/23 CVT CONVERTIBLE 1.375 15 Oct 23NOTE 1.375%10/10.93%$2M1.50M
20ASPNASPEN AEROGELS INCCOM0.82%$1M207.8K
21HEALTH CARE SELECT SECTOR HEDGEFUNDSBI HEALTHCARE0.81%$1M15.7K
22HZNP 2.500 03/15/22 CVT CONVERTIBLE 2.500 15 Mar 22NOTE 2.500% 3/10.68%$1M1.10M
23MXMAGNACHIP SEMICONDUCTCOM0.66%$1M116.0K
24SILICOM LTDORD0.64%$1M35.6K
25MUMICRON TECHNOLOGY INCCOM0.61%$1M28.6K
26LIQTECH INTERNATIONAL ORDCOM0.54%$975,00098.3K
27KNKNOWLES CORPCOM0.51%$930,00050.8K
28VUZIVUZIX CORPCOM NEW0.50%$895,000218.6K
29PGNXUSDPROGENICS PHARMACEUTICALSCOM0.47%$853,000138.4K
30AIRGAIRGAIN ORDCOM0.47%$849,00060.0K
31SPDR S&P BIOTECH ETF HEDGEFUNDS&P BIOTECH0.45%$806,0009.2K
32APPSDIGITAL TURBINE INCCOM0.44%$790,000157.9K
33Consumer Discretionary Select Sector SPDR Fund HEDGEFUNDSBI CONS DISCR0.43%$779,0006.5K
34ALLOT COMMUNICATIONS LTDSHS0.42%$755,000104.7K
35CALXCALIX INCCOM0.41%$737,000112.4K
36INDUSTRIAL SELECT SECT SPDR HEDGEFUNDSBI INT-INDS0.39%$706,0009.1K
37PXLWEURPIXELWORKS INCCOM NEW0.38%$690,000233.9K
38DERMEURDERMIRA INCCOM0.38%$683,00071.4K
39VANGUARD INFORMATION TECHNOLOGY ETFINF TECH ETF0.38%$680,0003.2K
40DMACDIAMEDICA THERAPEUTI ORDCOM0.36%$657,000132.5K
41QUIKGBPQUICKLOGIC CORPCOM0.36%$651,0001.13M
42RFILRF INDUSTRIES ORDCOM PAR $0.010.36%$646,00076.6K
43RIGLUSDRIGEL PHARMACEUTICALS INCCOM NEW0.33%$595,000227.9K
44CLFDCLEARFIELD INCCOM0.33%$590,00044.5K
45ADMSEURADAMAS PHARMACEUTICALS INCCOM0.30%$545,00087.9K
46DHXDHI GROUP INCCOM0.27%$488,000136.8K
47NLNKUSDNEWLINK GENETICS CORPCOM0.27%$483,000326.5K
48OESXUSDORION ENERGY SYSTEMS INCCOM0.25%$460,000155.0K
49DSP GROUP INCCOM0.24%$441,00030.7K
50QUMUEURQUMU ORDCOM0.24%$433,000104.4K
51XLFFINANCIAL SELECT SECTOR SPDR HEDGEFUNDSBI INT-FINL0.23%$414,00015.0K
52APTEVO THERAPEUTICS INCCOM0.22%$397,000447.7K
53FLNACASSAVA SCIENCES ORDCOM0.20%$359,000296.6K
54Consumer Staples Select Sector SPDR Fund HEDGEFUNDSBI CONS STPLS0.18%$317,0005.5K
55ZFGNUSDZAFGEN INCCOM0.17%$316,000265.6K
56SPDR S&P PHARMACEUTICALS ETFS&P PHARMAC0.15%$279,0007.0K
57AQMSEURAQUA METALS INCCOM0.15%$272,000162.8K
58INTEVAC ORDCOM0.15%$271,00056.0K
59NNDMUSDNANO DIMENSION ADRSPONS ADR0.14%$252,000524.7K
60AGXARGAN ORDCOM0.13%$232,0003.3K
61EFTTECHTARGETCOM0.12%$223,00010.5K
62BNGOUSDBIONANO GENOMICS ORDCOM0.12%$215,00087.5K
63LJPCLA JOLLA PHARMACEUTICAL COCOM PAR $.0001 2 · COM PAR $.0001 30.11%$204,00022.0K
64IZEA WORLDWIDE ORDCOM0.11%$193,000377.1K
65APOLLO ENDOSURGERY ORDCOM0.10%$180,00055.4K
66DRRXEURDURECT ORDCOM0.10%$172,000264.1K
67OGXIEURACHIEVE LIFE SCIENCES ORDCOM0.08%$139,00071.8K
68PDVWUSDPDVWIRELESS INCCOM0.06%$107,0002.3K
69XLCCommunication Services Select Sector SPDR FundCOMMUNICATION0.06%$102,0002.1K
70ONCOSEC MEDICAL ORDCOM0.05%$99,00039.2K
71ICADUSDICAD INCCOM0.05%$92,00014.4K
72XLBMATERIALS SELECT SECTOR SPDR HEDGEFUNDSBI MATERIALS0.05%$84,0001.4K
73REAL ESTATE SELECT SECT SPDR HEDGEFUNDRL EST SEL SEC0.04%$79,0002.2K
74XLUUTILITIES SELECT SECTOR SPDR HEDGEFUNDSBI INT-UTILS0.04%$79,0001.3K
75CORREVIO PHARMA ORDCOM0.04%$69,00031.9K
76BIONANO GENOMICS EQY WARRANT WRNT 6.13 21 Sep 23*W EXP 08/21/2020.04%$65,00088.4K
77NANOVIBRONIX ORDCOM0.03%$58,00019.9K
78FOAMIX PHARMACEUTICALS ORDSHS0.03%$56,00023.6K
79ENTERA BIO ORDSHS0.03%$49,00016.0K
80XLEENERGY SELECT SECTOR SPDR HEDGEFUNDENERGY0.01%$20,000321
81SANOFI CONTINGENT VALUE RTS RIGHTSRIGHT 12/31/20200.01%$15,00029.0K
82ENTERA BIO EQY WARRANT WRNT*W EXP 06/27/2020.00%$6,00014.0K
83SU6SURMODICS INCCOM0.00%$1,00034

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$32M55May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$14M53Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$34M64Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$65M42Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$53M36May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$10M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$14M49Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$13M56Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$15M63May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$185M130Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$169M163Nov 15, 202313F-HRchanges · EDGAR ↗
Q2 2023$184M173Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$205M194May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$169M183Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$163M183Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$170M150Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$217M148May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$202M130Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M130Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$269M115Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$206M111May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$126M101Feb 17, 202113F-HRchanges · EDGAR ↗
Q3 2020$122M220Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$204M220Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$162M198May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$204M178Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$175M193Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$181M197Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$180M204May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$132M209Feb 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • DLD Asset Management, LP028-17749

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.